广州医药 ›› 2023, Vol. 54 ›› Issue (12): 60-65.DOI: 10.3969/j.issn.1000-8535.2023.12.010

• 论著 • 上一篇    下一篇

改良直接抽吸取栓术治疗急性脑栓塞的有效性及安全性分析

黄华锰1, 胡桂和1, 关秩诗2, 欧阳樱君1   

  1. 1 广州市第一人民医院神经内科(广东广州 510180);
    2 广州市南沙区第一人民医院(广东广州 511462)
  • 收稿日期:2023-08-31 发布日期:2024-01-10
  • 通讯作者: 欧阳樱君,E-mail: eyouyangyingjun@scut.edu.cn
  • 基金资助:
    广州市科学技术局科研项目(202102080672); 南沙区科技局科研项目(2021MS005)

The efficacy and safety of modified-ADAPT of acute cerebral embolism

HUANG Huameng1, HU Guihe1, GUAN Zhishi2, OUYANG Yingjun1   

  1. 1 Department of Neurology,Guangzhou First People's Hospital,Guangzhou 510180,China;
    2 Guangzhou Nansha First People's Hospital,Guangzhou 511462,China
  • Received:2023-08-31 Published:2024-01-10

摘要: 目的 观察改良直接抽吸取栓术(ADAPT)治疗急性前循环大动脉栓塞性脑卒中的有效性与安全性。方法 回顾性分析2022年3月—2023年2月在广州市第一人民医院采用改良ADAPT治疗急性前循环大动脉栓塞性脑卒中的12例患者临床资料。该改良技术核心是血栓抽吸导管或颅内支持导管管头明确越过血栓后才开始直接使用20 mL的注射器进行手动持续抽吸;所有患者术后依据临床症状和影像表现启动规范抗凝药物治疗,每月门诊随访观察有无再发卒中。结果 12例患者闭塞血管均成功再通,其中改良脑梗死溶栓(mTICI )2b~2c级3例(25%),mTICI 3级9例(75%);从穿刺到血管再通平均时间为37.7 min,首次取栓再通8例(66.7%),其中颈内动脉闭塞首次取栓再通成功率达80%,出院时平均美国国立卫生研究院卒中量表(NIHSS)评分(9.00±9.22)分,与术前基础NIHSS评分相比,平均下降7分,术后90 d功能恢复良好(mRS评分0~2分)9例(75%);术后脑出血3例(25%),其中1例为小点状出血(HI1)而无明显症状、1例为血肿<梗死面积的30%并有轻微占位效应的出血(PH1)恢复良好、1例为血肿>梗死面积的30%并有明显占位效应的出血(PH2)术后自动出院,12例患者筛查病因均发现有心房纤颤,9例患者术后依据临床症状和影像表现在早期开展规范抗凝二级预防管理后无再复发。结论 改良ADAPT是治疗急性大动脉栓塞性脑卒中的一种安全可行选择,血管再通效率高,血栓逃逸概率低、临床疗效良好。对心房纤颤患者实施规范抗凝管理可有效预防脑卒中复发。

关键词: 卒中, 脑栓塞, 抽吸取栓, 心房纤颤

Abstract: Objective To observe the efficacy and safety of modified-a direct aspiration first-pass technique(ADAPT)in the treatment of acute anterior circulation aorta embolic stroke.Methods The clinical data of 12 patients with acute anterior circulation arterial embolic stroke treated by modified-ADAPT in our hospital from March 2022 to February 2023 were analyzed retrospectively.The core of the modified technique is that the head of the thrombus aspiration catheter or intracranial support catheter clearly crosses the thrombus before manual continuous suction with a 20 mL syringe.After operation,all patients started standard anticoagulant therapy according to clinical symptoms and imaging manifestations,and monthly outpatient follow-up was conducted to observe whether there was recurrent stroke.Results Occlusive vessels were successfully recanalized in 12 patients,including 3 cases(25%)of mTICI 2b-2c grade and 9 cases(75%)of mTICI 3 grade.The average time from puncture to vascular recanalization was 37.7 min,and the first thrombectomy and recanalization was performed in 8 cases(66.7%).The success rate of internal carotid artery occlusion was 80%.The average NIHSSS score at discharge was(9.00±9.22).Compared with the preoperative NIHSS score,the average score decreased by 7 points.90 days after operation,the function recovered well in 9 cases(75%).Postoperative cerebral hemorrhage occurred in 3 cases(25%),including 1 case of punctate hemorrhage without obvious symptoms,1 case of good recovery of PH1 and 1 case of automatic discharge after PH2.12 patients were found to have atrial fibrillation after screening,9 patients had no recurrence after anticoagulation secondary prevention management according to clinical symptoms and imaging manifestations.Conclusions Modified-ADAPT is a safe and feasible choice for the treatment of acute arterial embolism stroke,with high recanalization efficiency,low thrombus escape probability and good clinical effect.Standardized anticoagulation management can effectively prevent the recurrence of stroke in patients with atrial fibrillation.

Key words: stroke, cerebral embolism, a direct aspiration first-pass technique, atrial fibrillation